s6y Co-Diagnostics, Inc. S-8

Co-Diagnostics, Inc. S-8, filed Jan 23, 2023: ex107.htm

 

Exhibit 107

 

Calculation of Filing Fee Tables

 

Form S-8

(Form Type)

 

Co-Diagnostics, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

   Security
Type
  Security Class
Title
  Fee
Calculation
or Carry
Forward
Rule
  Amount
Registered (1)
   Proposed
Maximum
Offering
Price Per
Share (2)
   Maximum
Aggregate
Offering
Price (2)
   Fee Rate   Amount of
Registration
Fee (2)
 
Fees to Be Paid  Equity  Common Stock, $0.001 par value  Other   6,000,000   $2.83   $16,980,000    0.00011020   $1,871.20 
   Total Offering Amounts        $16,980,000        $1,871.20 
 Total Fees Previously Paid                  $0 
   Total Fee Offsets                  $0 
   Net Fee Due                  $1,871.20 

 

(1) Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement shall also cover any additional shares of the Registrant’s common stock that become issuable under the Registrant’s Amended and Restated 2015 Long Term Incentive Plan (the “2015 Plan”) in respect of the securities identified in the above table by reason of any stock dividend, stock split, recapitalization, or other similar transaction effected without the Registrant’s receipt of consideration that increases the number of the outstanding shares of the Registrant’s common stock.
   
(2) Pursuant to Rules 457(c) and (h) under the Securities Act, the proposed maximum offering price per share and the proposed maximum aggregate offering price are estimated for the purpose of calculating the amount of the registration fee and are based on the average of the high and low sales price of the Registrant’s common stock as reported on the Nasdaq Capital Market on January 19, 2023.